BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 6344769)

  • 41. The heterogeneity of Streptococcus viridans: therapeutic considerations in infective endocarditis.
    Fisher J; Levene DL
    Can Med Assoc J; 1975 May; 112(10):1217-9. PubMed ID: 1125890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of enterococcal septicemia and endocarditis].
    Bengtsson E; Svanbom M; Tunevall G
    Lakartidningen; 1971 Mar; 68(10):1087-92. PubMed ID: 5573786
    [No Abstract]   [Full Text] [Related]  

  • 43. [Infective endocarditis in the 80's. Lessons learned from past and present problems].
    Fernández Guerrero ML
    Rev Clin Esp; 1985 Nov; 177(8):406-14. PubMed ID: 3915371
    [No Abstract]   [Full Text] [Related]  

  • 44. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1983; 41():151-7. PubMed ID: 6589752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin.
    Henry NK; Wilson WR; Geraci JE
    Antimicrob Agents Chemother; 1986 Nov; 30(5):725-8. PubMed ID: 3800348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occurrence of prosthetic valve endocarditis due to oxacillin-sensitive and oxacillin- resistant. Staphylococci, and the possibility 5 of therapy.
    Nagy E; Kovács G; Földes J
    J Chemother; 1989 Jul; 1(4 Suppl):741-4. PubMed ID: 16312617
    [No Abstract]   [Full Text] [Related]  

  • 47. Vancomycin.
    Geraci JE
    Mayo Clin Proc; 1977 Oct; 52(10):631-4. PubMed ID: 909314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.
    Levy CS; Kogulan P; Gill VJ; Croxton MB; Kane JG; Lucey DR
    Clin Infect Dis; 2001 Aug; 33(4):577-9. PubMed ID: 11462199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infective endocarditis: a review. II. Diagnosis and treatment.
    Rao PS; Thapar MK; Linde LM
    Paediatrician; 1978; 7(1-3):85-99. PubMed ID: 724272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric endocarditis.
    Johnson CM; Rhodes KH
    Mayo Clin Proc; 1982 Feb; 57(2):86-94. PubMed ID: 7054627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
    Martínez F; Martín-Luengo F; García A; Valdés M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial therapy for two serious bacterial infections. Enterococcal endocarditis and nosocomial pneumonia.
    Sande MA
    Arch Intern Med; 1982 Oct; 142(11):2033-4. PubMed ID: 7125791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
    Gavaldà J; Pahissa A; Almirante B; Laguarda M; Crespo E; Pou L; Fernández F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals.
    Wilson WR; Zak O; Sande MA
    J Infect Dis; 1985 Jun; 151(6):1028-33. PubMed ID: 3846608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis.
    Fujitani S; Rowlinson MC; George WL
    Clin Infect Dis; 2008 Apr; 46(7):1064-6. PubMed ID: 18444825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis.
    Parrillo JE; Borst GC; Mazur MH; Iannini P; Klempner MS; Moellering RC; Anderson SE
    N Engl J Med; 1979 Feb; 300(6):296-300. PubMed ID: 252640
    [No Abstract]   [Full Text] [Related]  

  • 57. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
    Sande MA; Johnson ML
    J Infect Dis; 1975 Apr; 131(4):367-75. PubMed ID: 1117194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Enterococcal endocarditis: a multicenter study of 76 cases].
    Martínez-Marcos FJ; Lomas-Cabezas JM; Hidalgo-Tenorio C; de la Torre-Lima J; Plata-Ciézar A; Reguera-Iglesias JM; Ruiz-Morales J; Márquez-Solero M; Gálvez-Acebal J; de Alarcón-González A;
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):571-9. PubMed ID: 19477041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of rifampin against viridans streptococci.
    Stamm AM; Phillips EK
    South Med J; 1983 Aug; 76(8):964-5. PubMed ID: 6879290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic treatment of streptococcal and staphylococcal endocarditis. Report of a working party of the British Society for Antimicrobial Chemotherapy.
    Lancet; 1985 Oct; 2(8459):815-7. PubMed ID: 2864539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.